Entera Bio Ltd. (ENTX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 200K 400K 600K Q4 '21: 571K Q1 '22: 482K Q2 '22: 417K Q3 '22: 285K Q4 '22: 134K Q1 '23: 66K Q2 '23: 22K Q3 '23: 14K Q4 '23: 0 Q1 '24: 0 Q2 '24: 57K Q3 '24: 99K Q4 '24: 181K Q1 '25: 223K Q2 '25: 166K Q3 '25: 124K Q4 '25: 42K Q1 '26: 0 Q2 '26: 0 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 70K 140K 210K Q4 '21: 198K Q1 '22: 128K Q2 '22: 129K Q3 '22: 56K Q4 '22: 33K Q1 '23: 19K Q2 '23: 8K Q3 '23: 6K Q4 '23: 0 Q1 '24: 0 Q2 '24: 9K Q3 '24: 9K Q4 '24: 9K Q1 '25: 9K Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-15M -10M -5M 0 5M 10M 15M Q4 '21: -12.2M Q1 '22: -13.7M Q2 '22: -14.4M Q3 '22: -14M Q4 '22: -13M Q1 '23: -11.4M Q2 '23: -10.5M Q3 '23: -10M Q4 '23: -8.9M Q1 '24: -8.7M Q2 '24: -8.6M Q3 '24: -9.2M Q4 '24: -9.6M Q1 '25: -10.1M Q2 '25: -10.6M Q3 '25: -10.8M Q4 '25: -11.5M Q1 '26: -12.5M Q2 '26: -14.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-18M -12M -6M 0 6M 12M 18M Q4 '21: -12.2M Q1 '22: -13.7M Q2 '22: -14.3M Q3 '22: -14.1M Q4 '22: -13.1M Q1 '23: -11.5M Q2 '23: -10.6M Q3 '23: -9.9M Q4 '23: -8.9M Q1 '24: -8.7M Q2 '24: -8.5M Q3 '24: -9.2M Q4 '24: -9.5M Q1 '25: -10.1M Q2 '25: -10.6M Q3 '25: -10.8M Q4 '25: -11.4M Q1 '26: -12.4M Q2 '26: -17M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 150K 300K 450K Q4 '21: 373K Q1 '22: 354K Q2 '22: 288K Q3 '22: 229K Q4 '22: 101K Q1 '23: 47K Q2 '23: 14K Q3 '23: 8K Q4 '23: 0 Q1 '24: 0 Q2 '24: 48K Q3 '24: 90K Q4 '24: 172K Q1 '25: 214K Q2 '25: 166K Q3 '25: 124K Q4 '25: 42K Q1 '26: 0 Q2 '26: 0 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q4 '21: -9.1M Q1 '22: -11.5M Q2 '22: -12.2M Q3 '22: -13M Q4 '22: -12.5M Q1 '23: -9.3M Q2 '23: -8M Q3 '23: -6.7M Q4 '23: -7.3M Q1 '24: -7.6M Q2 '24: -7.3M Q3 '24: -8M Q4 '24: -6.8M Q1 '25: -6.4M Q2 '25: -6.7M Q3 '25: -7M Q4 '25: -7.4M Q1 '26: -9.1M Q2 '26: -10.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q4 '21: -9.1M Q1 '22: -11.6M Q2 '22: -12.3M Q3 '22: -13.1M Q4 '22: -12.5M Q1 '23: -9.4M Q2 '23: -8.1M Q3 '23: -6.7M Q4 '23: -7.3M Q1 '24: -7.6M Q2 '24: -7.3M Q3 '24: -8M Q4 '24: -6.8M Q1 '25: -6.4M Q2 '25: -6.7M Q3 '25: -7.1M Q4 '25: -7.5M Q1 '26: -9.2M Q2 '26: -11M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q2 '19: 11.7M Q2 '20: 18.2M Q2 '21: 24.7M Q3 '21: 28.7M Q1 '22: 28.8M Q2 '22: 28.8M Q3 '22: 28.8M Q1 '23: 28.8M Q2 '23: 28.8M Q3 '23: 28.8M Q1 '24: 36.7M Q2 '24: 37.1M Q3 '24: 37.6M Q1 '25: 43.4M Q2 '25: 46.8M Q3 '25: 47.1M Q1 '26: 47.8M Q2 '26: 50.5M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.20 0.40 0.60 Q4 '21: 0.46 Q1 '22: 0.49 Q2 '22: 0.50 Q3 '22: 0.50 Q4 '22: 0.45 Q1 '23: 0.40 Q2 '23: 0.37 Q3 '23: 0.34 Q4 '23: 0.31 Q1 '24: 0.28 Q2 '24: 0.26 Q3 '24: 0.26 Q4 '24: 0.25 Q1 '25: 0.26 Q2 '25: 0.26 Q3 '25: 0.25 Q4 '25: 0.26 Q1 '26: 0.27 Q2 '26: 0.35 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.